Cargando…

Construction and Evaluation of Recombinant Adenovirus Candidate Vaccines for Chikungunya Virus

Chikungunya virus (CHIKV) is a mosquito-borne virus. The emergence of CHIKV infection has raised global concern, and there is a growing need to develop safe and effective vaccines. Here, adenovirus 5 was used as the vaccine vector to construct recombinant adenoviruses expressing CHIKV E2, E1, and E2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Liang, Wang, Wei, Sun, Wenchao, Zhang, Jinyong, Han, Jicheng, Xie, Changzhan, Ha, Zhuo, Xie, Yubiao, Zhang, He, Jin, Ningyi, Lu, Huijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414632/ https://www.ncbi.nlm.nih.gov/pubmed/36016401 http://dx.doi.org/10.3390/v14081779

Ejemplares similares

Construction and immunological evaluation of recombinant adenovirus vaccines co-expressing GP3 and GP5 of EU-type porcine reproductive and respiratory syndrome virus in pigs
por: XIE, Changzhan, et al.
Publicado: (2019)

Synergistic Pathogenicity by Coinfection and Sequential Infection with NADC30-like PRRSV and PCV2 in Post-Weaned Pigs
por: Zhang, Jinyong, et al.
Publicado: (2022)

Pathogenicity of Seneca Valley virus in pigs and detection in Culicoides from an infected pig farm
por: Zhang, Jinyong, et al.
Publicado: (2021)

Immunological evaluation of recombination PRRSV GP3 and GP5 DNA vaccines in vivo
por: Zhao, Guanyu, et al.
Publicado: (2022)

Codon Usage for Genetic Diversity, and Evolutionary Dynamics of Novel Porcine Parvoviruses 2 through 7 (PPV2–PPV7)
por: Xie, Changzhan, et al.
Publicado: (2022)

Construction and Characterization of a Novel Recombinant Attenuated and Replication-Deficient Candidate Human Adenovirus Type 3 Vaccine: “Adenovirus Vaccine Within an Adenovirus Vector”
por: Yan, Yuqian, et al.
Publicado: (2020)

Genetic variation analysis of PCV1 strains isolated from Guangxi Province of China in 2015
por: Cao, Liang, et al.
Publicado: (2018)

Molecular Detection and Genetic Characterization of Japanese Encephalitis Virus in Animals from 11 Provinces in China
por: Zhao, Guanyu, et al.
Publicado: (2023)

Recombinant Oncolytic Adenovirus Combined with Cyclophosphamide Induces Synergy in the Treatment of Breast Cancer in vitro and in vivo
por: Wang, Jing, et al.
Publicado: (2022)

Establishment of a reverse transcription real-time quantitative PCR method for Getah virus detection and its application for epidemiological investigation in Shandong, China
por: Cao, Xinyu, et al.
Publicado: (2022)

Toll-like receptor 2 signaling pathway activation contributes to a highly efficient inflammatory response in Japanese encephalitis virus-infected mouse microglial cells by proteomics
por: Zhao, Guanyu, et al.
Publicado: (2022)

Construction, expression and antiviral activity analysis of recombinant adenovirus expressing human IFITM3 in vitro
por: Du, Shouwen, et al.
Publicado: (2019)

A comparative study of the ability of recombinant oncolytic adenovirus, doxorubicin and tamoxifen to inhibit the proliferation of breast cancer cells
por: Li, Shanzhi, et al.
Publicado: (2022)

Construction and immunogenicity of an mRNA vaccine against chikungunya virus
por: Liu, Jingjing, et al.
Publicado: (2023)

A novel and simple method for construction of recombinant adenoviruses
por: Tan, Rong, et al.
Publicado: (2006)

Recombinant Hexon Protein as a New Bovine Adenovirus Type 3 Subunit Vaccine Candidate
por: Gundegmaa, Uudamsaikhan, et al.
Publicado: (2023)

Genome Sequences of a Novel Recombinant Duck Circovirus in China
por: Sun, Wenchao, et al.
Publicado: (2016)

Chikungunya Vaccine Candidates: Current Landscape and Future Prospects
por: Schmidt, Christin, et al.
Publicado: (2022)

New recombinant adenovirus used as vaccine; dog adenovirus-2 vector; dog parvovirus, cat panleukopenia virus, cat or dog coronavirus, dog distemper virus, cat leukemia virus, rabies virus or FIV virus recombinant vaccine construction
Publicado: (1992)

Construction and immune evaluation of the recombinant duck adenovirus type 3 delivering capsid protein VP1 of the type 1 duck hepatitis virus
por: Wen, Yongsen, et al.
Publicado: (2023)

Insights from the Construction of Adenovirus-Based Vaccine Candidates against SARS-CoV-2: Expecting the Unexpected
por: Weklak, Denice, et al.
Publicado: (2023)

Construction and Preparation of Three Recombinant Adenoviruses Expressing Truncated NS3 and Core Genes of Hepatitis C Virus for Vaccine Purposes
por: Hosseini, Seyed Younes, et al.
Publicado: (2012)

Modified Vaccinia Virus Ankara as a Viral Vector for Vaccine Candidates against Chikungunya Virus
por: García-Arriaza, Juan, et al.
Publicado: (2021)

Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy
por: Watanabe, Maki, et al.
Publicado: (2021)

A novel recombinant serotype 4 fowl adenovirus expressing fiber-2 protein of duck adenovirus 3
por: Guo, Yiwen, et al.
Publicado: (2023)

Construction and characterization of a recombinant human adenovirus vector expressing bone morphogenetic protein 2
por: ZHANG, ZHENG, et al.
Publicado: (2013)

Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties
por: Liu, Yan, et al.
Publicado: (2014)

Development of Adenovirus-Based Covid-19 Vaccine Candidate in Indonesia
por: Artarini, Anita, et al.
Publicado: (2023)

Chikungunya Virus Vaccine Candidates with Decreased Mutational Robustness Are Attenuated In Vivo and Have Compromised Transmissibility
por: Carrau, Lucía, et al.
Publicado: (2019)

Attenuation and Stability of CHIKV-NoLS, a Live-Attenuated Chikungunya Virus Vaccine Candidate
por: Abeyratne, Eranga, et al.
Publicado: (2018)

Mutating chikungunya virus non‐structural protein produces potent live‐attenuated vaccine candidate
por: Chan, Yi‐Hao, et al.
Publicado: (2019)

Construction of Novel Thermostable Chimeric Vaccine Candidates for Genotype VII Newcastle Disease Virus
por: Cao, Yongzhong, et al.
Publicado: (2022)

Immunogenicity and Efficacy of a Recombinant Human Adenovirus Type 5 Vaccine against Zika Virus
por: Steffen, Tara, et al.
Publicado: (2020)

A novel fiber-2-edited live attenuated vaccine candidate against the highly pathogenic serotype 4 fowl adenovirus
por: Xie, Quan, et al.
Publicado: (2021)

Assessment of the immunogenicity and protection of a Nipah virus soluble G vaccine candidate in mice and pigs
por: Gao, Zihan, et al.
Publicado: (2022)

Adenovirus vectored IFN-α protects mice from lethal challenge of Chikungunya virus infection
por: Chen, Huixin, et al.
Publicado: (2020)

Optimized production and immunogenicity of an insect virus-based chikungunya virus candidate vaccine in cell culture and animal models
por: Adam, Awadalkareem, et al.
Publicado: (2021)

A Chikungunya Virus Multiepitope Recombinant Protein Expressed from the Binary System Insect Cell/Recombinant Baculovirus Is Useful for Laboratorial Diagnosis of Chikungunya
por: da Silva, Leonardo Assis, et al.
Publicado: (2022)

Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19
por: Capone, Stefania, et al.
Publicado: (2021)

Anti-tumor Synergistic Effect of a Dual Cancer-Specific Recombinant Adenovirus and Paclitaxel on Breast Cancer
por: Wang, Jing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3r3sn0i7minseeu5olq6lkibhk